CN114989475B - Preparation method and product application of biological functionalized surface modified polyether-ether-ketone material - Google Patents
Preparation method and product application of biological functionalized surface modified polyether-ether-ketone material Download PDFInfo
- Publication number
- CN114989475B CN114989475B CN202210600645.3A CN202210600645A CN114989475B CN 114989475 B CN114989475 B CN 114989475B CN 202210600645 A CN202210600645 A CN 202210600645A CN 114989475 B CN114989475 B CN 114989475B
- Authority
- CN
- China
- Prior art keywords
- ether
- polyether
- ketone
- preparing
- surface modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/12—Chemical modification
- C08J7/123—Treatment by wave energy or particle radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/12—Chemical modification
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/12—Chemical modification
- C08J7/14—Chemical modification with acids, their salts or anhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/06—Coatings containing a mixture of two or more compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2327/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Derivatives of such polymers
- C08J2327/02—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Derivatives of such polymers not modified by chemical after-treatment
- C08J2327/12—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Derivatives of such polymers not modified by chemical after-treatment containing fluorine atoms
- C08J2327/16—Homopolymers or copolymers of vinylidene fluoride
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2477/00—Characterised by the use of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Derivatives of such polymers
- C08J2477/04—Polyamides derived from alpha-amino carboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种生物功能化表面改性的聚醚醚酮材料的制备方法和产品应用,属于生物医用高分子材料技术领域。The invention relates to a preparation method and product application of a biologically functionalized surface-modified polyetheretherketone material, belonging to the technical field of biomedical polymer materials.
背景技术Background technique
聚醚醚酮(PEEK)具有良好的体外和体内生物相容性,无毒性、无致畸、无致突变、致癌效应,而且放射线可以透过,磁共振扫描中也不会产生伪影。目前,PEEK及其复合材料已成为材料学家和骨科专家研究的热点,且已有椎间融合器、人工关节假体等应用于临床并取得了良好的近期随访效果。然而,PEEK是生物惰性及疏水性的,缺乏生物活性,难以进行化学修饰,植入体内后不能很好地与宿主骨进行骨整合,极大地限制了其在临床上的广泛应用。Polyetheretherketone (PEEK) has good in vitro and in vivo biocompatibility, non-toxic, non-teratogenic, non-mutagenic, and carcinogenic effects, and can transmit radiation, and will not produce artifacts in magnetic resonance scanning. At present, PEEK and its composite materials have become a research hotspot for material scientists and orthopedic experts, and intervertebral fusion devices, artificial joint prostheses, etc. have been applied clinically and achieved good recent follow-up results. However, PEEK is biologically inert and hydrophobic, lacks biological activity, is difficult to chemically modify, and cannot be well osseointegrated with the host bone after implantation, which greatly limits its wide clinical application.
在不破坏PEEK材料本征众多优异性能的前提下,采用表面改性的方法赋予其生物活性是解决上述问题的有效途径,即通过物理或化学方法制备生物活性涂层使PEEK功能化。既往文献报道中,许多涂层(包括磷酸钙、生物活性小分子、羟基磷灰石、钛等)在增强PEEK植入物的骨整合方面具有实用价值。然而,这些方法仍然存在许多亟待解决的问题,包括涂层易降解、化学步骤复杂耗时、涂层与基底粘结不良等。此外,PEEK植入物的表面修饰目前主要侧重于提高生物活性、促进细胞生长或避免感染等多功能特性,这些也是促进PEEK植入物生理骨整合所必须的重要功能。目前,针对PEEK表面功能化以便同时获得抗感染和促进生长等关键功能的研究报道较少,实际临床应用更是稀缺。On the premise of not destroying the many excellent properties of PEEK materials, it is an effective way to solve the above problems by using surface modification methods to endow them with biological activity, that is, to prepare bioactive coatings by physical or chemical methods to functionalize PEEK. In previous literature reports, many coatings (including calcium phosphate, bioactive small molecules, hydroxyapatite, titanium, etc.) have practical value in enhancing the osseointegration of PEEK implants. However, there are still many problems to be solved in these methods, including easy degradation of the coating, complex and time-consuming chemical steps, and poor adhesion between the coating and the substrate. In addition, the surface modification of PEEK implants is currently mainly focused on multifunctional properties such as improving bioactivity, promoting cell growth, or avoiding infection, which are also important functions necessary to promote the physiological osseointegration of PEEK implants. At present, there are few research reports on the surface functionalization of PEEK to obtain key functions such as anti-infection and growth promotion at the same time, and the actual clinical application is even scarcer.
发明内容Contents of the invention
本发明所要解决的技术问题在于克服PEEK材料生物惰性,通过常温下化学接枝对PEEK表面处理,并仅通过浸泡手段非共价结合荧光分子和药物分子,形成涂层,赋予其包括抗感染促进生长等多种生物功能。The technical problem to be solved by the present invention is to overcome the biological inertia of the PEEK material, treat the surface of PEEK by chemical grafting at room temperature, and non-covalently combine fluorescent molecules and drug molecules only by soaking to form a coating, endowing it with anti-infection promotion Growth and other biological functions.
为了实现上述目的,本发明的技术方案为:In order to achieve the above object, the technical solution of the present invention is:
所述聚醚醚酮材料是通过注塑成型、3D打印、预浸等工艺制备的具有特定形状的,且外层或整体为聚醚醚酮的材料,且所述聚醚醚酮材料表面经生物功能化改性处理。The polyether ether ketone material is prepared by injection molding, 3D printing, prepreg and other processes with a specific shape, and the outer layer or the whole is polyether ether ketone material, and the surface of the polyether ether ketone material is biologically treated. Functional modification treatment.
所述经生物功能化改性处理具体是,所述的聚醚醚酮材料经等离子体处理后,通过浸泡工艺将活化层化学接枝聚醚醚酮材料表面,进行改性。The modification by biofunctionalization is specifically, after the polyetheretherketone material is treated with plasma, the activation layer is chemically grafted on the surface of the polyetheretherketone material through a soaking process to modify it.
所述的浸泡工艺为通过酸化在表面产生羧基,羧基与超支化聚赖氨酸酰胺化反应形成带正电的涂层即活化层;所述的涂层由于含有带正电的超支化聚赖氨酸,可以与带负电的荧光分子和/或促生长药物非共价高效负载结合。The soaking process is to generate carboxyl groups on the surface by acidification, and the carboxyl groups react with hyperbranched polylysine amidation to form a positively charged coating, that is, an activation layer; because the coating contains positively charged hyperbranched polylysine Amino acids, which can be conjugated with negatively charged fluorescent molecules and/or growth-promoting drugs for non-covalent high-efficiency loading.
所述的荧光分子为异硫氰酸荧光素、FAM马来酰亚胺、罗丹明、磺酰罗丹明101、5-羧甲基罗丹明、1-氨基萘-8-羧酸德克萨斯红、5-(碘乙酰胺基)荧光素中的至少一种。The fluorescent molecules are fluorescein isothiocyanate, FAM maleimide, rhodamine, sulforhodamine 101, 5-carboxymethylrhodamine, 1-aminonaphthalene-8-carboxylic acid Texas At least one of red and 5-(iodoacetamido)fluorescein.
所述的促生长药物为他克莫司、普立宁钾、奥拉西坦、阿仑膦酸钠中的至少一种。The growth-promoting drug is at least one of tacrolimus, pulinin potassium, oxiracetam, and alendronate sodium.
所述聚醚醚酮材料制备方法具体为:The preparation method of the polyether ether ketone material is specifically:
1)将聚醚醚酮材料通过注塑成型、3D打印、预浸等工艺制备成修复区域所需形状;1) Prepare the polyetheretherketone material into the desired shape of the repaired area through injection molding, 3D printing, prepreg and other processes;
2)活化表面:将PEEK材料放置在等离子体处理仪中进行表面活化。2) Activate the surface: place the PEEK material in a plasma processor for surface activation.
3)共价结合:经等离子体处理过的PEEK材料立即放置于按重量计,0.1-5mol/L丙烯酸溶液中,加热,取出并用水冲洗三次;配制超支化聚赖氨酸溶液,加入10-50份1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐活化,再加入10-50份N-羟基琥珀酰亚胺活化,放入丙烯酸处理过的PEEK材料,常温反应过夜,取出后水冲洗三次,干燥即可。3) Covalent bonding: The PEEK material treated by plasma is immediately placed in a 0.1-5mol/L acrylic acid solution by weight, heated, taken out and rinsed with water three times; to prepare a hyperbranched polylysine solution, add 10- Activate with 50 parts of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, add 10-50 parts of N-hydroxysuccinimide for activation, and put in acrylic acid-treated PEEK material , react overnight at room temperature, rinse with water three times after taking it out, and dry it.
4)非共价负载:将1-10份带负电的荧光分子或者药物配制成溶液,将PEEK材料放入,搅拌,取出干燥即可。4) Non-covalent loading: Prepare 1-10 parts of negatively charged fluorescent molecules or drugs into a solution, put the PEEK material in, stir, take out and dry.
所述的功能化表面改性的聚醚醚酮材料具有高效负载促生长药物,从而促进细胞生长,以及抗感染的性能。The functionalized surface-modified polyetheretherketone material has the properties of efficiently loading growth-promoting drugs, thereby promoting cell growth, and resisting infection.
所述的促进细胞增长为促进小鼠胚胎成骨细胞前体细胞生长。The promoting cell growth is promoting the growth of mouse embryonic osteoblast precursor cells.
所述抗感染性能,具体为抗金黄色葡萄球菌和大肠杆菌。The anti-infection performance is specifically anti-Staphylococcus aureus and Escherichia coli.
本发明的有益效果在于:The beneficial effects of the present invention are:
本发明提供提供一种稳定高效的生物活性修饰,即通过等离子体处理后,仅通过室温浸泡便可以化学接枝,丙烯酸化的PEEK,不改变材料本体的机械性能,同时具有促进成骨细胞成骨分化并有显著的杀菌效果的多种生物学性能。本发明工艺简单、效率高、重复性较好,可以改善目前PEEK骨科植入物应用于临床的缺点。The present invention provides a stable and efficient bioactive modification, that is, after plasma treatment, it can be chemically grafted only by soaking at room temperature, and the acrylated PEEK does not change the mechanical properties of the material body, and at the same time has the ability to promote osteoblast formation. Various biological properties of bone differentiation and significant bactericidal effect. The invention has the advantages of simple process, high efficiency and good repeatability, and can improve the shortcomings of the current clinical application of PEEK orthopedic implants.
附图说明Description of drawings
图1:PEEK经丙烯酸改性前后实物图;Figure 1: The physical picture of PEEK before and after acrylic acid modification;
图2:PEEK经丙烯酸改性前后的水接触角表征;Figure 2: Characterization of water contact angle of PEEK before and after modification with acrylic acid;
图3:PEEK改性后对大肠杆菌和金黄色葡萄球菌的抗感染性能。Figure 3: Anti-infection properties of PEEK modified against Escherichia coli and Staphylococcus aureus.
图4:PEEK经硫酸改性后实物图;Figure 4: The physical picture of PEEK modified by sulfuric acid;
具体实施方式Detailed ways
所举实施例是为了更好地对本发明进行说明,但并不是本发明的内容仅局限于所举实施例。熟悉本领域的技术人员根据上述发明内容对实施方案进行非本质的改进和调整,仍属于本发明的保护范围。The examples given are for better description of the present invention, but the content of the present invention is not limited to the examples given. Non-essential improvements and adjustments made by those skilled in the art to the embodiments based on the above content of the invention still belong to the protection scope of the present invention.
实施例1Example 1
将聚醚醚酮熔体通过3D打印机打印成颅骨修复所需形状并放置在等离子体处理仪中,调整参数,辉光放电20min。经等离子体处理过的PEEK颅骨修复植入物立即放置于配制的0.5mol/L丙烯酸溶液中浸泡30min,取出并用水冲洗三次;配制超支化聚赖氨酸溶液,加入50mmol/L的EDC活化20min,再加入50mmol/L NHS活化1h,放入丙烯酸处理过的PEEK颅骨修复植入物,常温反应过夜,取出后水冲洗三次,干燥即可。将带负电的荧光分子罗丹明、药物阿仑膦酸钠配制成3mg/mL的溶液,将PEEK颅骨修复植入物放入,常温搅拌30min,取出干燥即可。The polyether ether ketone melt was printed into the shape required for cranial repair by a 3D printer and placed in a plasma processor, the parameters were adjusted, and the glow discharge was performed for 20 minutes. The plasma-treated PEEK skull repair implants were immediately placed in the prepared 0.5mol/L acrylic acid solution and soaked for 30 minutes, taken out and rinsed with water three times; the hyperbranched polylysine solution was prepared and activated by adding 50 mmol/L EDC for 20 minutes , then add 50mmol/L NHS to activate for 1h, put in the acrylic-treated PEEK skull repair implant, react overnight at room temperature, take it out, rinse it with water three times, and dry it. The negatively charged fluorescent molecule rhodamine and the drug alendronate sodium were prepared into a 3 mg/mL solution, and the PEEK skull repair implant was put in, stirred at room temperature for 30 minutes, and then taken out and dried.
未经任何处理的聚醚醚酮标记为PEEK,化学接枝处理后的聚醚醚酮记作PEEK-AAc,其外观展示图如图1所示。在室温下,在PEEK和改性后PEEK上测量静态接触角,其结果如图2所示。在经过接枝处理后的PEEK接触角由80°降低到20°,说明经过表面处理后,显著提高了PEEK的亲水性。PEEK without any treatment is marked as PEEK, and PEEK after chemical grafting is marked as PEEK-AAc, and its appearance is shown in Figure 1. At room temperature, the static contact angle was measured on PEEK and modified PEEK, and the results are shown in Figure 2. After grafting treatment, the contact angle of PEEK decreased from 80° to 20°, indicating that the hydrophilicity of PEEK was significantly improved after surface treatment.
本实施例采用的细胞为小鼠成骨细胞前体细胞,但其它小鼠成体干细胞(脂肪间充质干细胞、骨髓间充质干细胞等)等具有成骨分化潜能的干细胞同样适用于本发明。所用的测试样品分为三组:Bare PEEK(未改性PEEK),PEEK-AAc(化学接枝的PEEK),PEEK-AAc-AS(化学接枝后负载药物阿仑膦酸钠的PEEK)。将三组样品消毒灭菌后置于48孔板中每组设3个复孔,小鼠胚胎成骨细胞前体细胞(MC3T3-E1)接种于各组材料上,控制细胞密度(2×104/ml),每孔500μL;接种后1天和3天,每个PEEK样品用磷酸盐缓冲液(PBS)洗涤;在预定的时间点使用CCK-8法研究细胞的增殖。未改性的PEEK组,在1天和3天的试验期材料表面都没有细胞增殖。PEEK-AAc组,在1天和3天对细胞的增殖都有促进作用。此外,相比PEEK-AAc组,负载了促生长药物阿仑膦酸钠的PEEK-AAc-AS组促进细胞增殖的效果有明显提高。The cells used in this example are mouse osteoblast precursor cells, but other mouse adult stem cells (adipogenic mesenchymal stem cells, bone marrow mesenchymal stem cells, etc.) and other stem cells with osteogenic differentiation potential are also suitable for the present invention. The test samples used were divided into three groups: Bare PEEK (unmodified PEEK), PEEK-AAc (chemically grafted PEEK), PEEK-AAc-AS (chemically grafted PEEK loaded with drug alendronate sodium). The three groups of samples were sterilized and placed in a 48-well plate with 3 replicate holes for each group. Mouse embryonic osteoblast precursor cells (MC3T3-E1) were inoculated on the materials of each group, and the cell density was controlled (2×10 4 /ml), 500 μL per well; 1 day and 3 days after inoculation, each PEEK sample was washed with phosphate-buffered saline (PBS); cell proliferation was studied using the CCK-8 method at predetermined time points. In the unmodified PEEK group, there was no cell proliferation on the surface of the material during the 1-day and 3-day test periods. In the PEEK-AAc group, the proliferation of cells was promoted on day 1 and day 3. In addition, compared with the PEEK-AAc group, the effect of promoting cell proliferation in the PEEK-AAc-AS group loaded with the growth-promoting drug alendronate was significantly improved.
本实施例采用稀释涂布平板法评估材料的抗菌性能。具体操作如下:将PEEK片放入24孔板中,用LB培养基将菌液浓度稀释到1×106CFU/mL。在每块PEEK材料表面滴加25μL菌液,将孔板各孔之间的缝隙用PBS填满,以减缓水分蒸发,置于37℃培养箱中培养4h;取出后,每孔再加入1975μL的PBS,将材料和液体同时转移至一新的离心管中。将离心管置于超声水浴(功率40W)中超声5min,再用涡旋振荡器震荡30s,以充分将粘附的细菌洗脱下来;将配好的LB固体培养基溶液高压灭菌后,于50℃下保温,趁还未凝固前向平板中倒入约15mL液体,匀平冷却凝固后即得固体培养基;将上述收集的菌液经过梯度稀释后,取100μL滴在平板中央,用涂布器涂抹均匀,置于37℃培养箱中培养16个小时;菌落长出后,拍照并统计平板上菌落的数目。以纯PEEK组作为对照,抗菌率计算方法为:抗菌率=(对照组CFU-实验组CFU)/对照组CFU×100%。试验结果如图3所示,未改性的PEEK材料不具有抗菌能力,PEEK-AAc组对大肠杆菌和金黄色葡萄球菌的抗菌率分别可达69%和43%,说明表面接枝HBPL的材料对革兰氏阳性菌和革兰氏阴性菌均有非常良好的抗菌效果。In this embodiment, the antibacterial performance of the material is evaluated by the dilution coating plate method. The specific operation is as follows: put the PEEK sheet into a 24-well plate, and dilute the concentration of the bacterial solution to 1×10 6 CFU/mL with LB medium. Add 25 μL of bacterial solution dropwise on the surface of each PEEK material, fill the gap between the wells of the orifice plate with PBS to slow down the evaporation of water, and place it in a 37°C incubator for 4 hours; after taking it out, add 1975 μL of bacterial solution to each well PBS, transfer material and liquid simultaneously to a new centrifuge tube. Place the centrifuge tube in an ultrasonic water bath (power 40W) and sonicate for 5 minutes, then oscillate with a vortex oscillator for 30 seconds to fully elute the adhered bacteria; after autoclaving the prepared LB solid medium solution, Keep warm at 50°C, pour about 15mL of liquid into the plate before it solidifies, and then obtain a solid medium after cooling and solidifying evenly; after gradient dilution of the bacterial solution collected above, take 100 μL and drop it on the center of the plate, and use Spread the cloth evenly, and place it in an incubator at 37°C for 16 hours; after the colonies grow, take pictures and count the number of colonies on the plate. Taking the pure PEEK group as the control, the antibacterial rate calculation method is: antibacterial rate=(control group CFU-experimental group CFU)/control group CFU×100%. The test results are shown in Figure 3. The unmodified PEEK material has no antibacterial ability, and the antibacterial rates of E. coli and Staphylococcus aureus in the PEEK-AAc group can reach 69% and 43%, respectively, indicating that the material grafted with HBPL on the surface It has very good antibacterial effect on Gram-positive bacteria and Gram-negative bacteria.
实施例2Example 2
将聚醚醚酮熔体通过3D打印机打印成颅骨修复所需形状并放置在等离子体处理仪中,调整参数,辉光放电20min。经等离子体处理过的PEEK颅骨修复植入物立即放置于配制的0.5mol/L硫酸溶液中浸泡30min,取出并用水冲洗三次;配制超支化聚赖氨酸溶液,加入50mmol/L的EDC活化20min,再加入50mmol/LNHS活化1h,放入丙烯酸处理过的PEEK颅骨修复植入物,常温反应过夜,取出后水冲洗三次,干燥。将带负电的荧光分子罗丹明或者药物阿仑膦酸钠配制成3mg/mL的溶液,将PEEK颅骨修复植入物放入,常温搅拌30min,经干燥处理后获得生物功能化表面改性的聚醚醚酮材料,其外观展示图如图4所示。The polyether ether ketone melt was printed into the shape required for cranial repair by a 3D printer and placed in a plasma processor, the parameters were adjusted, and the glow discharge was performed for 20 minutes. The plasma-treated PEEK skull repair implants were immediately placed in the prepared 0.5mol/L sulfuric acid solution and soaked for 30 minutes, taken out and rinsed with water three times; the hyperbranched polylysine solution was prepared and activated by adding 50 mmol/L EDC for 20 minutes , then add 50mmol/L NHS to activate for 1h, put into the acrylic-treated PEEK skull repair implant, react overnight at room temperature, take it out, rinse it with water three times, and dry it. The negatively charged fluorescent molecule rhodamine or the drug alendronate sodium was prepared into a 3 mg/mL solution, the PEEK skull repair implant was put into it, stirred at room temperature for 30 minutes, and the biofunctional surface modified polymer was obtained after drying. Ether ether ketone material, its appearance is shown in Figure 4.
对比例1Comparative example 1
根据现有技术中的方法制备PEEK颅骨修复植入物(如CN114214592A,一种增强3D打印PEEK材料生物相容性的表面处理方法)对聚醚醚酮(PEEK)表面进行处理,提高表面光洁度,消除3D打印PEEK表面粉尘颗粒,其具体处理工序为:喷砂:将3D打印PEEK材料首先进行喷砂处理;打磨抛光:将经过喷砂处理的PEEK材料在砂纸及金刚石研磨膏下进行打磨抛光处理;超声波清洗:将经过喷砂处理的PEEK材料置于丙酮溶液中进行超声震荡清洗;采用物理气相沉积(PVD)技术,将纯Ta沉积在聚醚醚酮的表面上,得到PEEK基涂层材料。对比例1总制备时间较为2-3天,处理过程需要用到大量设备,能源耗费大,制备过程复杂且繁琐。且重金属在植入物涂层中,长期植入后有释放的风险。Prepare PEEK skull repair implant according to the method in the prior art (such as CN114214592A, a kind of surface treatment method that strengthens the biocompatibility of 3D printing PEEK material) polyether ether ketone (PEEK) surface is treated, improves surface smoothness, To eliminate dust particles on the surface of 3D printed PEEK, the specific treatment process is as follows: sandblasting: the 3D printed PEEK material is first sandblasted; grinding and polishing: the sandblasted PEEK material is ground and polished under sandpaper and diamond abrasive paste ; Ultrasonic cleaning: put the sandblasted PEEK material in an acetone solution for ultrasonic cleaning; use physical vapor deposition (PVD) technology to deposit pure Ta on the surface of polyetheretherketone to obtain a PEEK-based coating material . The total preparation time of Comparative Example 1 is relatively 2-3 days, the processing process requires a lot of equipment, the energy consumption is large, and the preparation process is complicated and cumbersome. Moreover, heavy metals are in the implant coating, and there is a risk of release after long-term implantation.
对比例2Comparative example 2
根据现有技术中的方法制备PEEK颅骨修复植入物(如CN111116964A,生物功能化表面改性的聚醚醚酮材料及其制备方法与应用)所述的制备方法具体为:将聚醚醚酮材料浸在的强酸溶液中0.5h,然后在去离子水中浸泡24h以除去多余的酸,然后用去离子水超声清洗3次,每次20min,干燥,得到表面改性的聚醚醚酮材料。总制备时间虽然短,酸化后仅改善了PEEK的亲水性能,且表面不稳定,无法长期作用于人体。而通过本发明公开的一种生物功能化表面改性的聚醚醚酮材料的制备方法和产品应用可以在共计24h内通过常温下化学接枝对PEEK表面处理,并仅通过浸泡手段非共价结合荧光分子和药物分子,形成涂层,赋予其包括抗感染促进生长等多种生物功能。Prepare PEEK skull repair implants according to the methods in the prior art (such as CN111116964A, polyether ether ketone material with biological functionalization surface modification and its preparation method and application) The preparation method is specifically: polyether ether ketone The material was immersed in a strong acid solution for 0.5h, then soaked in deionized water for 24h to remove excess acid, and then ultrasonically cleaned with deionized water for 3 times, each time for 20min, and dried to obtain a surface-modified polyether ether ketone material. Although the total preparation time is short, the hydrophilic property of PEEK is only improved after acidification, and the surface is unstable, so it cannot act on the human body for a long time. However, through the preparation method and product application of a biologically functionalized surface-modified polyetheretherketone material disclosed in the present invention, the surface of PEEK can be treated by chemical grafting at room temperature within a total of 24 hours, and non-covalent Combine fluorescent molecules and drug molecules to form a coating, endowing it with various biological functions including anti-infection and promoting growth.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210600645.3A CN114989475B (en) | 2022-05-30 | 2022-05-30 | Preparation method and product application of biological functionalized surface modified polyether-ether-ketone material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210600645.3A CN114989475B (en) | 2022-05-30 | 2022-05-30 | Preparation method and product application of biological functionalized surface modified polyether-ether-ketone material |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114989475A CN114989475A (en) | 2022-09-02 |
CN114989475B true CN114989475B (en) | 2023-07-18 |
Family
ID=83032142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210600645.3A Active CN114989475B (en) | 2022-05-30 | 2022-05-30 | Preparation method and product application of biological functionalized surface modified polyether-ether-ketone material |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114989475B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115400267B (en) * | 2022-10-10 | 2023-03-03 | 吉林大学 | Preparation method and application of a polyether ether ketone composite material loaded with rosmarinic acid |
CN118406273B (en) * | 2024-05-29 | 2024-11-19 | 广东安拓普聚合物科技股份有限公司 | A TPU material for medical catheters and its production process |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106421922A (en) * | 2016-10-09 | 2017-02-22 | 太原理工大学 | Modified hydroxyapatite/carbon nanotube/polyetheretherketon composite material and preparation method thereof |
DE102017118508A1 (en) * | 2017-08-14 | 2019-02-14 | Verein zur Förderung von Innovationen durch Forschung, Entwicklung und Technologietransfer e.V. (Verein INNOVENT e.V.) | Method for producing a biocompatible layer on an implant surface |
CN113185740A (en) * | 2021-04-29 | 2021-07-30 | 华东理工大学 | Method for improving antibacterial activity and biocompatibility of substrate surface |
CN113354786A (en) * | 2021-07-07 | 2021-09-07 | 苏州大学附属第一医院 | Method for preparing difunctional polyether-ether-ketone by using mussel-derived peptide in combination with bioorthogonal reaction and application thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008086147A1 (en) * | 2007-01-05 | 2008-07-17 | The Brigham And Women's Hospital, Inc. | Compositions and methods for the repair and regeneration of cartilage and/or bone |
KR101770827B1 (en) * | 2011-03-10 | 2017-08-23 | 서울대학교산학협력단 | Stent for selectively capturing epc and process for producing the same |
KR101302557B1 (en) * | 2011-08-16 | 2013-09-02 | 충북대학교 산학협력단 | Method For Preparing Polymeric Biomaterials Having Immobilized Drug Delivery System Comprising Bioactive Molecules Loaded Particulate Carrier |
US11098203B2 (en) * | 2016-08-31 | 2021-08-24 | Commonwealth Scientific And Industrial Research Organisation | Polymer coatings |
CN112472875A (en) * | 2019-09-12 | 2021-03-12 | 天津大学 | Heparinized magnetic nanoparticles and preparation method and application thereof |
CN111035803B (en) * | 2019-11-07 | 2021-07-06 | 浙江大学 | A titanium implant material with both anti-infection and osseointegration functions and preparation method thereof |
CN113527748B (en) * | 2021-07-12 | 2023-01-03 | 南方科技大学 | Polyether-ether-ketone surface modification method, polyether-ether-ketone obtained through modification and application of polyether-ether-ketone |
CN113713172B (en) * | 2021-09-08 | 2023-04-11 | 深圳清华大学研究院 | In-situ endothelialization promoting coating and preparation method thereof |
CN114470324B (en) * | 2022-02-08 | 2023-04-04 | 福建医科大学附属协和医院 | Novel strategy for the modification of universal bone implants for the intervention of bone defects associated with diabetes |
-
2022
- 2022-05-30 CN CN202210600645.3A patent/CN114989475B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106421922A (en) * | 2016-10-09 | 2017-02-22 | 太原理工大学 | Modified hydroxyapatite/carbon nanotube/polyetheretherketon composite material and preparation method thereof |
DE102017118508A1 (en) * | 2017-08-14 | 2019-02-14 | Verein zur Förderung von Innovationen durch Forschung, Entwicklung und Technologietransfer e.V. (Verein INNOVENT e.V.) | Method for producing a biocompatible layer on an implant surface |
CN113185740A (en) * | 2021-04-29 | 2021-07-30 | 华东理工大学 | Method for improving antibacterial activity and biocompatibility of substrate surface |
CN113354786A (en) * | 2021-07-07 | 2021-09-07 | 苏州大学附属第一医院 | Method for preparing difunctional polyether-ether-ketone by using mussel-derived peptide in combination with bioorthogonal reaction and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN114989475A (en) | 2022-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhou et al. | Collagen functionalized with graphene oxide enhanced biomimetic mineralization and in situ bone defect repair | |
CN114989475B (en) | Preparation method and product application of biological functionalized surface modified polyether-ether-ketone material | |
Zhou et al. | Improving osteogenesis of three-dimensional porous scaffold based on mineralized recombinant human-like collagen via mussel-inspired polydopamine and effective immobilization of BMP-2-derived peptide | |
Abinaya et al. | Chitosan in surface modification for bone tissue engineering applications | |
Yang et al. | Pearl powder hybrid bioactive scaffolds from microfluidic 3D printing for bone regeneration | |
CN107661544B (en) | Antibacterial and osteopromoting composite functional porous orthopedic implant and preparation method thereof | |
Yao et al. | 3D interpenetrated graphene foam/58S bioactive glass scaffolds for electrical-stimulation-assisted differentiation of rabbit mesenchymal stem cells to enhance bone regeneration | |
CN111097068B (en) | Bionic hydroxyapatite powder/gelatin/sodium alginate composite 3D printing support and preparation method thereof | |
CN104353124B (en) | A 3D printed porous metal scaffold of a composite magnetic nanomaterial and its preparation method | |
CN106702341B (en) | Polyetheretherketonematerials materials and based on plasma immersion injection method of modifying and application | |
CN107693843A (en) | The surface modifying method of biomedical active titanium and its alloy implantation material | |
Kurian et al. | Surface-engineered hybrid gelatin methacryloyl with nanoceria as reactive oxygen species responsive matrixes for bone therapeutics | |
CN107185055A (en) | A kind of surface modifying method of medical magnesium alloy | |
Chen et al. | Biocompatible octacalcium phosphate/sodium alginate/silk fibroin composite scaffolds for bone regeneration | |
Li et al. | Hydrogel coatings of implants for pathological bone repair | |
Cheng et al. | Osteoinduction mechanism of calcium phosphate biomaterials in vivo: a review | |
CN108144119A (en) | A kind of method that antibacterial Sodium Hyaluronate and chitosan bilayer are prepared on Biological magnesium alloy surface apatite coating | |
Liu et al. | Stability, biomechanics and biocompatibility analysis following different preparation strategies of hierarchical zeolite coatings on titanium alloy surfaces | |
Jiang et al. | A mussel-inspired osteogenesis microenvironment with bioactive peptides for the dual-functionalization of biomedical substrates | |
Ceccarelli et al. | In vitro osteogenesis of human stem cells by using a three-dimensional perfusion bioreactor culture system: a review | |
Nafary et al. | Electrospun poly-L-lactic acid coated with silicate bioceramic nanoparticles enhance osteogenic differentiation of adipose tissue derived mesenchymal stem cells | |
CN113144290B (en) | Orthopedic material surface coating for promoting bone and immune regulation and preparation method thereof | |
CN116059442A (en) | Repairing material with polyether-ether-ketone as matrix and preparation method and application thereof | |
Oktay et al. | Graphene-based materials for bone tissue engineering | |
Zhou et al. | Surface functionalization of titanium with BMP-7/RGD/hyaluronic acid for promoting osteoblast functions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |